Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kabiven Dosing in Pediatric Patients
NCT03481894Phase 4Withdrawn
- Sponsor
- Fresenius Kabi
- Start
- Mar 2018
- Primary completion
- Mar 2020
- Modality
- Lipid-based Nanoparticles, Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Kabiven in Malnutrition, sponsored by Fresenius Kabi. Planned start Mar 2018; status: withdrawn.
02
Drugs
Kabiven
03
Conditions
Malnutrition
Beyond the preview
Go deeper on NCT03481894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03481894.